• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eurosurv. Emergence of a novel subclade of influenza A(H3N2) virus in London, December 2016 to January 2017

tetano

Editor, Senior Moderator
Eurosurveillance, Volume 22, Issue 8, 23 February 2017
Rapid communication

Emergence of a novel subclade of influenza A(H3N2) virus in London, December 2016 to January 2017


H Harvala [SUP]1[/SUP] [SUP]2[/SUP] , D Frampton [SUP]2[/SUP] , P Grant [SUP]1[/SUP] , J Raffle [SUP]2[/SUP] , RB Ferns [SUP]2[/SUP] [SUP]3[/SUP] , Z Kozlakidis [SUP]2[/SUP] , P Kellam [SUP]4[/SUP] , D Pillay [SUP]2[/SUP] , A Hayward [SUP]5[/SUP] , E Nastouli [SUP]1[/SUP] [SUP]3[/SUP] [SUP]6[/SUP] , For the ICONIC Consortium [SUP]7[/SUP]
+ Author affiliations
1. Department of Clinical Virology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
2. Department of Infection and Immunity, University College of London, London, United Kingdom
3. NIHR UCLH/UCL Biomedical Research Centre, London, United Kingdom
4. Department of Medicine, Imperial College Faculty of Medicine, London, United Kingdom
5. Department of Infectious Disease Informatics, Farr Institute of Health Informatics Research, London, United Kingdom
6. Department of Population, Policy and Practice, UCL GOS Institute of Child Health, London, United Kingdom
7. The members of these networks are listed at the end of the article


Correspondence: Eleni Nastouli (e.nastouli@ucl.ac.uk), Heli Harvala (heli.harvala@uclh.nhs.uk)








Citation style for this article: Harvala H, Frampton D, Grant P, Raffle J, Ferns RB, Kozlakidis Z, Kellam P, Pillay D, Hayward A, Nastouli E, For the ICONIC Consortium. Emergence of a novel subclade of influenza A(H3N2) virus in London, December 2016 to January 2017. Euro Surveill. 2017;22(8):pii=30466. DOI: http://dx.doi.org/10.2807/1560-7917.ES.2017.22.8.30466

Received:13 February 2017; Accepted:23 February 2017

[h=4][/h]
We report the molecular investigations of a large influenza A(H3N2) outbreak, in a season characterised by sharp increase in influenza admissions since December 2016. Analysis of haemagglutinin (HA) sequences demonstrated co-circulation of multiple clades (3C.3a, 3C.2a and 3C.2a1). Most variants fell into a novel subclade (proposed as 3C.2a2); they possessed four unique amino acid substitutions in the HA protein and loss of a potential glycosylation site. These changes potentially modify the H3N2 strain antigenicity.

full article

http://eurosurveillance.org/ViewArticle.aspx?ArticleId=22720
 
Back
Top Bottom